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ABSTRACT 
Recent breakthroughs in artificial intelligence (AI), specifically via its emerging sub-field 
“Deep Learning,” have direct implications for computer-aided detection and diagnosis 
(CADe/CADx) for colonoscopy. AI is expected to have at least 2 major roles in colonoscopy 
practice; polyp detection (CADe) and polyp characterization (CADx). CADe has the potential to 
decrease polyp miss rate, contributing to improving adenoma detection, whereas CADx can 
improve the accuracy of colorectal polyp optical diagnosis, leading to reduction of unnecessary 
polypectomy of non-neoplastic lesions, potential implementation of a resect and discard 
paradigm, and proper application of advanced resection techniques. A growing number of 
medical-engineering researchers are developing both, CADe and CADx systems, some of which 
allow real-time recognition of polyps or in vivo identification of adenomas with over 90% 
accuracy. However, the quality of the developed AI systems as well as that of the study designs 
vary significantly, hence raising some concerns regarding the generalization of the proposed AI 
systems. Initial studies were conducted in an exploratory or retrospective fashion using stored 
images and likely overestimating the results. These drawbacks potentially hinder smooth 
implementation of this novel technology into colonoscopy practice. The aim of this article is to 
review both contributions and limitations in recent machine learning based CADe/CADx 
colonoscopy studies and propose some principles that should underlie system development and 
clinical testing. 
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INTRODUCTION 
Artificial intelligence (AI) has the potential to improve the quality of medical diagnosis 
and treatment. Loosely inspired by neural networks in the human brain, “Deep Learning (DL)” is 
capable of autonomously extracting and learning features from big data of healthcare (ie, 
imaging, genetics, healthcare records, and most -omics data) by the means of  a multilayered 
system called convolutional neural networks.1–5 It usually outperforms the traditional (non-deep 
learning based) machine learning methods, which extract features that scientists themselves 
interpreted and picked up based on experience. Such features are often called as hand-crafted 
features in machine learning literature. 
In the field of gastrointestinal endoscopy, computer-aided detection and diagnosis 
(CADe/CADx) in colonoscopy is garnering increased attention and investigation.6,7 AI will have 
2 major initial roles in colonoscopy practice: (1) automated polyp detection (CADe) and (2) 
automated polyp histology characterization (CADx). CADe can minimize the probability of 
missing a polyp during colonoscopy, and thereby improving the adenoma detection rate (ADR) 
and potentially decreasing the incidence of interval cancer.8 CADx can improve colorectal polyp 
optical diagnosis, leading to reduction in the resection of clinically inconsequent distal non-
neoplastic lesions, potential implementation of a resect and discard paradigm and proper use of 
advanced resection methods such as endoscopic submucosal dissection and surgery.  
More than 100 studies regarding AI in colonoscopy have been published in both 
engineering and medical fields.6,7,9 However, the quality of the developed AI systems vary 
significantly as well as that of the study designs exploring their performance.  Most of the 
previous studies were conducted in an experimental or retrospective fashion and the performance 
of AI in colonoscopy has not been sufficiently assessed in terms of its effectiveness and 
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reproducibility in actual clinical practice, though such pre-clinical studies are considered 
indispensable in the early research phase.  
The goal of this review is to provide direction and facilitate appropriate research and 
development of CADe/CADx systems for colonoscopy. We especially highlight the following 
issues in this article: benefits and disadvantages of AI, published literature, current limitations, 
features of ideal CADe/CADx system, study design, training, and education, regulatory approval 
and legal issues. 
 
BENEFITS of AI 
a. CADe  
A major goal of CADe in colonoscopy is to prevent missing polyps during colonoscope 
withdrawal, potentially increasing ADR as well as the number of adenomas per colonoscopy 
(APC). Lower miss rates, and thus higher ADR are strongly associated with a reduced 
incidence of postcolonoscopy colorectal cancers (CRC) and CRC-related mortality.10  
b. CADx 
The purpose of CADx is to predict the pathology of the detected polyps during colonoscopy. 
The potential benefit of CADx is to improve the accuracy of optical biopsy (eg, in vivo 
differentiation between neoplastic and non-neoplastic polyps using endoscopic light 
properties without tissue acquisition), thereby minimizing pathological assessment and 
unnecessary resection of distal non-neoplastic polyps leading to significant reduction in 
costs.11 In addition, it would facilitate the implementation of the “resect and discard” 
strategy12 into clinical practice even by inexperienced endoscopists. Future applications of 
CADx will include AI assessment of bowel preparation quality, lesion size measurement, 
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morphology description, identification of lesion features associated with deep and superficial 
submucosal invasion of cancer, real time guidance of therapeutic procedures, and automated 
report generation. 
 
DISADVANTAGES of AI 
There are potential drawbacks of AI in colonoscopy. One prospective study investigating 
real-time use of CADx pointed out that the time required for colonoscopy was estimated to 
increase by 35 to 47 seconds per polyp assessed with CADx.13 Also, the output from 
CADe/CADx might distract the concentration of the endoscopists, and if inaccurate, may lead to 
missing/mischaracterization of polyps.14 Reliance and/or dependence on AI may make the new 
generation of endoscopists less skillful and meticulous given the sense of security provided by 
this tool. Future prospective studies should assess the impact of these AI “pitfalls” in addition to 
its efficacy. 
 
PREVIOUS CONTRIBUTIONS 
In this section, we focus on clinically relevant, physician-initiated studies on AI in 
colonoscopy. Early research work mostly focused on technical development by computer-vision 
and engineering groups, and those are left outside the scope of this review.15–20  
a) CADe  
An early physician-initiated study on automated polyp detection was published by 
Fernandez-Esparrach et al in 2016. They used polyp boundaries information to identify polyps 
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effectively. They assessed their CADe model on video recordings of 31 polyps and obtained a 
sensitivity and specificity of >70%.19 After this study, three additional studies on automated 
polyp detection were published, all of which used DL algorithms. Misawa et al21 developed a 
real time CADe algorithm and assessed its performance using 50 polyp videos and 85 non-polyp 
videos, resulting in a sensitivity and a specificity of 90% and 63%, respectively. Urban et al22 
also developed a CADe model and reported an area under the curve of 0.991 (a measure in which 
values of 0.5 correspond to chance observation and 1.0 is perfect accuracy) and an accuracy of 
96%. Wang et al23 also developed a CADe model reporting over 90% values in both sensitivity 
and specificity. From a technical perspective, these researchers have dealt with polyp detection 
with already available or minimally changed DL models. Different from these retrospective 
analyses, Klare et al24 conducted a prospective evaluation of a CADe model based on hand-
drafted features. Their model achieved a 29.1% ADR in 55 colonoscopies, using the number of 
adenomas found by blinded experienced endoscopists as a reference standard. 
b) CADx 
Compared with CADe in which white-light endoscopy is used as the target of the image 
analysis, several optical technologies can be used for CADx: white light endoscopy,25,26 
magnifying narrow-band imaging (NBI),27–32 magnifying chromoendoscopy,33 
endocytoscopy,13,34–37 confocal laser endomicroscopy,38,39 spectroscopy,40,41 and 
autofluorescence endoscopy.42,43,44 Among these, the most extensively studied has been 
magnifying NBI;29 probably because it may have better diagnostic performance than 
nonmagnified NBI and does not require staining like dye-based chromoendoscopy that can be 
time consuming in routine clinical use.  
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CADx for magnifying NBI was first reported by Tischendorf  et al27 in 2010. After their 
work, several researchers developed CADx systems that were designed to differentiate adenomas 
from hyperplastic polyps based on conventional machine learning methods in early 2010s.28,30 
Their models focused on vascular patterns on the polyp surface for adenoma characterization and 
showed >90% sensitivities and specificities. Subsequently, Kominami et al29 successfully 
evaluated their model in a prospective study, showing a 93.0% sensitivity, 93.3% specificity, 
93.0% positive predictive value (PPV), and 93.3% negative predictive value (NPV). Their study 
also demonstrated >92.7% accuracies in predicting the surveillance interval based on optical 
diagnosis of diminutive polyps using CADx. Recently, 2 research teams conducted retrospective 
studies on newly developed CADx systems based on DL algorithms, both of which met the 
threshold that optical biopsy technologies require for implementation and adoption in clinical 
practice, namely >90% NPV for diagnosis of diminutive (≤5 mm) adenomas.31,32  
 CADx for endocytoscopy has also been investigated by a Japanese group. Endocytoscopy 
is performed with a colonoscope with a 520-fold ultra-magnifying function (CF-H290ECI, 
Olympus Corp). Although the availability of this technology is more limited than that of a 
magnifying colonoscope, endocytoscopy has ideal features for CADx. With endocytoscopy, 
endoscopists do not need to indicate the region of interest during polyp assessment given its 
ultra-magnification power once the tip of the device is in contact with the lesion. After several 
pilot studies,34,35,37,45,46 this research group conducted a large-scale prospective study using 
CADx, demonstrating 91.4% sensitivity, 91.7% specificity, 88.9% PPV, and 93.7% NPV in the 
classification of diminutive rectosigmoid adenomas. 
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 Laser-induced fluorescence (LIF) spectroscopy is another type of imaging modality 
investigated in this field. Rath et al. evaluated LIF spectroscopy CADx prospectively, reporting 
100% sensitivity, 80.6% specificity, 33.3% PPV, and 100% NPV for diminutive distal 
adenomas.41 However, another study by Kuiper et al40 demonstrated less-impressive results with 
83.0% sensitivity, 59.7% specificity, 71.6% PPV, and 74.2% NPV for diminutive adenomas. 
CADx for white-light endoscopy, the most common endoscopic modality, has not been as 
extensively investigated compared with other CADx.7 Recently, 2 research groups published 
preliminary results in this field; Komeda et al25 developed a DL model, providing 75.1% 
accuracy with a cross-validation method. Sanchez-Montes et al26 developed a handcrafted, 
predictive model based on 3 metrics (contrast, tubularity, and branching) of the polyp surface 
pattern, resulting in 95.0% sensitivity, 87.9% specificity, 82.6% PPV, and 96.7% NPV for 
diminutive rectosigmoid adenomas. 
CADx has also been explored for other modalities such as confocal laser endomicroscopy38,39 
and autofluorescence endoscopy.42,43 However, the number of publications and performance of 
the developed models are limited when compared with the aforementioned modalities. 
 
CURRENT LIMITATIONS of AI   
 Most studies to date have developed and evaluated CADe/CADx systems using stored static 
and video images. These are often selected as “ideal” images of endoscopist detected lesions, and 
therefore the results are not truly representative of real-world effectiveness and may not be 
reproducible in clinical practice.  
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 Also, pathology, which is usually used as “ground truth” for training CADx, is not always a 
gold standard. For example, considerable interobserver variation can be found in pathological 
diagnosis of sessile serrated lesions (SSLs), which creates a limitation for characterization of 
SSLs by means of AI. Another limitation is the lack of data on detection of inflammation and 
dysplasia in ulcerative and Crohn’s colitis, though pilot studies in this field can be found.47,48  
The black-box nature of the current DL algorithms can be another limitation; DL algorithms 
fail to reason the machine generated decision on polyp classification in CADx. Reasons causing 
the decision of the DL model are being investigated, and interpretable deep learning has already 
become an active area of research. 
 
IDEAL AI SYSTEM  
An ideal AI system includes at least five features: algorithm selection; ability to work real-
time; appropriate output styles; smart setup of the computer; and appropriately curated data set 
for machine learning.  
a) Algorithm selection 
Before the DL era, machine learning algorithms were developed by extracting hand-crafted 
features (ie, features that are determined by the users)  for classification of medical 
images.13,28,29,34 In the DL era, algorithms learn defining features thorough exposure of images to 
deep neural networks.21–23,31,32 Briefly, in the handcrafted algorithms, experts train computer 
systems with known features (eg, polypoid shape, surface features, vascular features) and use 
these features to detect and classify polyps later in test images. In contrast, DL algorithms 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 9
identify significant features from the image by a repetitive learning process. When using DL for 
CADe/CADx in colonoscopy, researchers should bear in mind several issues: DL algorithms 
usually but not necessarily outperform handcrafted algorithms49; although most DL algorithms 
are openly available (eg, Le-Net, AlexNet, VGG, GoogLeNet, ResNet) and can be installed even 
by “non-experts,” they still require expertise and time to tune numerous parameters to achieve 
the best performance. This process usually entails support from industrial or engineering partners.  
b) Ability to work real-time during colonoscopy 
Ideally the detection and characterization of colorectal polyps should be performed by the AI 
system real-time during colonoscopy. For this purpose, the computer that analyzes the 
endoscopic images should be directly connected to the endoscopy unit. In addition, latency from 
capturing endoscopic image frames to outputting the analyzed results should be as short as 
possible, because detection of polyps with CADe later than endoscopist’s detection will not be 
really useful.24 To shorten the latency, it is necessary to improve the computer algorithms and 
use high-specification computer systems. 
c) Appropriate output styles 
CADe is capable of outputting 2 variables including the presence and location of polyps. 
Polyp presence is indicated by audible or visible alarm outside the endoscopic monitor (Figure 1-
a)21, whereas polyp location is indicated by a visible rectangle or circle that highlights the polyp 
(Figure 1-b).22,23 Each type of output has pros and cons. The former method provides no 
information regarding polyp location, thus endoscopist has to search for them. On the other hand, 
its output does not distract endoscopists’ attention during optical assessment of the polyp. The 
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latter method that makes it easier for the endoscopist to localize the polyp, but may be distracting 
for histology assessment. 
Output of CADx also includes 2 kinds of patterns: pathology prediction34,37,50 (eg, non-
neoplastic or neoplastic) and endoscopic classification that can then be extrapolated to the 
histopathology of the polyp29,31 (eg, NICE classification51, Sano’s classification52, or Hiroshima 
classification53). Similarly, each type of output has pros and cons. The former method is 
considered more clinically beneficial and relevant because histopathological prediction is most 
useful in decision making, whereas the latter is not always a perfect indicator of pathology.54 
However, because the pathology prediction can directly influence clinical decision making, 
regulatory approval may be more difficult.  
Regarding monitor number, dual monitor-based system (one for endoscopic image, the other 
for CADe/CADx) is discouraged. Taking human’s visual fields into consideration, the output of 
AI and endoscopic image should be displayed preferably in one monitor. Several studies have 
demonstrated that certain visual gaze patterns on the monitor are associated with higher adenoma 
detection.55 It is not yet known if CADe systems will alter visual gaze patterns and if this will 
improve or worsen lesion detection. Thus, visual display is an important area for research.  
 
d) Smart setup of the computer  
Assembling a stand-alone type computer in an endoscopy room is the most suitable way of 
implementing AI into practice smoothly. However, emerging DL technologies require high-
specification in hardware setup, imposing constraints on size of the workstation and create 
cooling challenges. Server-based computing or cloud-computing are attractive alternatives 
because they may solve such installation hurdles in the endoscopy room. Nonetheless, latency 
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related with internet-connection speed and risk of leakage of patient’s personal information are 
some pitfalls of cloud-computing systems. 
 
e) Appropriately curated data set for machine learning 
Whether CADe/CADx employs a conventional hand-crafted feature extraction based 
algorithm or a DL algorithm, both quality and quantity of the machine learning material is 
important to enhance its performance. Regarding the quality of the material, 3 factors should be 
noted: imaging modality (static images or video recordings), prevalence of positive images, and 
quality of annotation (ie, labeling each image frame with true data such as neoplastic/non-
neoplastic or polyp/non-polyp). 
Importantly, video recordings are the ideal and recommended learning material. Video 
contains a much larger number of image frames than static images (1second video usually 
includes 30 image frames). Video recordings also contain valuable low-quality images which 
usually cannot be found in static image collections because endoscopists tend to capture good-
quality endoscopic static pictures (eg, non-blur, less stool, polyp is centered). Learning from 
low-quality images contributes to the robustness of the AI system. 
AI systems should be trained with images that have an adequate representation of the target 
patient population, with a balanced proportion of polyp and non-polyp images; neoplastic and 
non-neoplastic images, and high- and low-quality images. It cannot be extrapolated to 
populations with “unnatural” disease prevalence unless the likelihood ratio is adjusted in the 
developed algorithm.56 
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The quality of annotations is extremely important. For fully supervised learning process, 
researchers should precisely annotate all the image frames (eg, non-polyp or polyp image), 
which will be used for machine learning. Especially when researchers use video recordings as 
learning material (sometimes exceed 100,000 image frames21), the annotation process will be 
likely performed by research-assistants. In that case, confirmation by expert endoscopists is 
mandatory to ensure the quality and accuracy of the learning material. On that premise, accurate 
annotations for such “big data” may require significant investment of time and resources. 
Finally, a larger number of learning images contribute to a higher diagnostic accuracy, 
though the minimum number to reach learning plateau is still in an exploratory stage. The DL 
model type is another parameter that will affect the data size. Newer algorithms (such as 
Tiramisu57 and SegCaps 58) require 50% to 90% fewer parameters than conventional DL 
methods. To alleviate big data problems in medical imaging, DL researchers often use 2 
strategies: (1) transfer learning, and (2) data augmentation. In transfer learning59,60, the new DL 
model is updated from a pretrained network model which is obtained from other fields such as 
computer vision ImageNET where millions of natural images are made available with precise 
labels to train a typical neural network. In data augmentation, on the other hand, new data are 
artificially generated by using the available data with certain realistic manipulations such as 
rotating, translating, adding noise, flipping, etc. By this way, the data size can be increased 
considerably.61 
 
STUDY DESIGN 
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a) Endpoints 
CADe  
i) Preferable endpoints  
ADR is considered one of the best quality metric and endpoints to assess endoscopists’ 
performance in clinical practice.62 However, a limitation of ADR is that it only addresses the 
first adenoma found, and thus does not consider the possibility of missing subsequent adenomas. 
Adenoma per colonoscopy (APC) may be a more suitable endpoint to assess the ability of a 
CADe system to improve adenoma detection as it includes all adenomas detected per 
procedure.63 In addition, polyp miss rate (PMR) is also a good option as a primary endpoint 
for clinical validation  
 
ii) Definition and threshold of endpoint metrics: 
ADR: defined as the proportion of screening colonoscopies performed by a physician that detect 
at least one histologically confirmed adenoma or adenocarcinoma.64 The guidelines recommend 
ADR minimum thresholds of 25%,65 which might be used for the performance threshold of 
CADe. One relevant measure of success would be to increase ADR from a lower group (e.\g, 
quintile as defined by Corley et al62) to a higher group.  
APC: defined as the total number of adenomas found in all colonoscopies divided by the total 
number of colonoscopies. APC has a shown a good correlation with ADR in several studies.66 A 
study by Kahi et al suggested that APC of 0.5 for males and 0.2 for females correspond to the 
current benchmarks for ADR.67  
PMR: Defined as the total number of polyps missed from the first colonoscopy/the total number 
of polyps detected by both the first and the second (tandem) colonoscopy. Studies have shown 
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roughly 20%68 of polyps were missed during colonoscopy, thus, a PMR of <20% may be used as 
a threshold for assessment of CADe. PMR can be evaluated in data sets in which 2 
colonoscopies are performed on the same patients in a back-to-back manner, the second 
procedure may serve as a reference standard for missed lesions. In this case, missed lesions 
likely need to be subclassified as recognition errors (polyp on screen but not recognized) or 
demonstration errors (polyp hidden from view by fold, shadow, mucous, etc).  
 ADR, APC, and PMR should be evaluated with in vivo use of CADe during 
colonoscopy, but additional effect of CADe can also be independently identified in a prospective 
fashion if 2 rooms are prepared for the assessment (one for an endoscopist, the other for a CADe 
assessor)24. 
    
CADx  
i) Preferable endpoints  
The recommended thresholds proposed by the American Society of Gastrointestinal 
Endoscopy (ASGE) PIVI are appropriate targets to be achieved by CADx.69  
ii) Definition and threshold of endpoint metrics 
PIVI-1– resect and discard paradigm: To assess whether endoscopic optical biopsy 
technologies―when used with high confidence―provide ≥90% agreement in assignment of 
post-polypectomy surveillance compared with decisions based on histopathology. 69 
PIVI-2 – diagnose and leave paradigm: To assess whether the technology - when used with high 
confidence - provides a 90% or greater NPV for adenomatous histology in diminutive 
rectosigmoid polyps.69   
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 A caveat to AI systems is that they can both detect and classify polyps70, both of which may 
alter the surveillance interval. Thus, when measuring the CADx outcome, this can be assessed 
either separately (eg, the surveillance prediction when the CADx classifies only human-detected, 
and pathologically confirmed polyps) or comprehensively (eg, the surveillance prediction based 
on CADe plus CADx).  
b. Frequently adopted study design and its issues  
The vast majority of CADe/CADx systems have been evaluated in an experimental or 
retrospective fashion, whereas only a couple of studies were conducted prospectively with in 
vivo use of AI.13,24,41,71 The steps of such experimental/retrospective studies include (1) 
Retrospective/prospective collection of colonoscopy images or videos. (2) Dividing the dataset 
into training, validation, and test data. (3) AI training with the training data and evaluated with 
the validation data for ensuring the correctness of the training procedure, and subsequently 
evaluated with test data. (4) Comparison of AI’s performance with the endoscopists’ 
performance for the same test data.  
The most problematic issue of this kind of study design is the risk of selection bias; 
researchers tend to exclude low-quality images from the test set or omit “difficult-for-AI” cases. 
In addition, retrospective studies are not able to detect limitations of real-time use of AI such as 
additional time for the examination, endoscopist’s stress burden, level of expertise and 
confidence, performance with low quality images and control for missing data.14  In this regard, 
prospective studies on AI can provide more reliable information13,24,29,40,41. However, selection 
bias was still not eliminated in such prospective studies because they were single-arm with no 
controls for comparison. In the United States, the National Institutes of Health (NIH) classifies 
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diagnostic trials into 4 categories: phase I to phase Ⅳ. A similar classification should be used for 
AI trials and should be accurately reported in scientific manuscripts.   
c. Optimal study design 
Consideration of epidemiological factors is crucial to the interpretation of the model’s output. 
Randomized controlled clinical trials (RCTs) comparing colonoscopy with AI versus 
colonoscopy without AI represent the best methodology to analyze the tool’s performance, safety 
and limitations.72,73 This assessment should not be limited to centers with high experience in 
colonoscopy, otherwise, results should be adjusted to the level of expertise to preserve 
generalizability of recommendations. In addition, testing the model’s performance in different 
datasets with diverse content to what was used for machine training is important to ensure 
external validation.56 
      Currently, there has been no RCT on AI in colonoscopy published, except for one as an 
abstract.74 An example of a successfully performed RCT assessing CADx in the gynecology field 
was published in 2017. Pregnant women (N=47,062) were randomized to fetal heart rate 
machine interpretation and no machine interpretation, evaluating neonatal outcomes as the 
primary endpoint.75 The study was not positive for machine interpretation, though the pilot 
studies provided good results.76 This study emphasizes the need for full, real-world validation of 
AI systems before their routine use in clinical practice.  
 
TRAINING AND EDUCATION  
a. Required training to use AI 
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Because AI serves just as an adjunct to both detection and characterization of colorectal 
polyps (by no means an autonomous robot), basic insertion and withdrawal skill for colonoscopy 
is still required, though some AI software was designed to improve the quality of mucosal 
exposure during colonoscopy withdrawal.77 In addition, if the AI is designed for special 
endoscopy such as magnifying endoscopy, endocytoscopy, or confocal laser endomicroscopy, 
training to capture stable endoscopic images is also required. Once endoscopists acquire these 
basic skills, they may be able to achieve a high diagnostic performance with the use of AI 
comparable with that of experts. According to a prospective study that evaluated the use of 
CADx for optical biopsy in-vivo, the nonexpert group provided 95.0% NPV for diminutive 
rectosigmoid adenomas whereas the expert group showed 91.3% NPV.13  
 
b. Education  
Because AI is new to most endoscopists, education programs are considered mandatory 
before it is adopted in clinical practice. Knowledge of strengths and weaknesses of AI can 
contribute to the effective use of AI and also prevent unnecessary adverse events related to its 
use. Especially, through an education program, endoscopists should recognize that AI sometimes 
outputs wrong predictions and endoscopists’ final diagnosis can be strongly influenced and 
swayed by them.78 For example, a study of 30 internal medicine residents showed that they 
exhibited a decrease in diagnostic accuracy from 57% to 48% when electrocardiograms were 
annotated with inaccurate CADx.79 Importantly, endoscopists should be trained and educated 
about the legal responsibilities they might face before AI is implemented. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 18
On the other hand, CADx can potentially be a valuable tool for education and training of the 
lesser experienced endoscopists as the endoscopist might be able to compare their thought 
process and diagnostic suspicion with CADx output.  
 
REGULATORY APPROVAL AND LEGAL ISSUES 
a) Regulatory approval 
Because CADe/CADx for colonoscopy potentially affects the endoscopists’ decision 
making, obtaining regulatory approval will be required for its practical use. The hurdle of 
obtaining approval differs according to countries and role of AI in clinical practice.80 East et al81 
proposed three roles of CADx for colonoscopy. A second observer, a concurrent observer, or an 
independent decision maker. If CADx is aimed to be used independently, outstanding results 
from rigorously designed clinical trials will be required for its approval. In the United States, the 
Food and Drug Administration (FDA) recently moved to reclassify CADe software for radiology 
to allow an easier regulatory path to market82,83. For example, CADe for mammography will 
require class II approval, which used to require class III approval. This means that industries will 
no longer be required to submit a premarket approval application (PMA) for which conduct of 
either nonclinical or clinical trial under supervision of FDA is requested but can instead submit a 
less burdensome premarket notification (510(k)) before marketing their device.82  CADe for 
colonoscopy may be able to follow a similar pattern in its approval and regulation process. 
b) Legal issues 
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AI is not always beneficial for patients’ care.78 Some previous studies on CADe for 
mammography82 and CADx for electrocardiography79 demonstrated a negative effect in practice 
(CADe/CADx contributed to misdiagnosis). Such unintended, potentially negative effects of AI 
can result in legal challenges, therefore, medical malpractice insurance needs to be clear about 
coverage when healthcare decisions are made in part by AI.7,84 Public guidance for the 
development of AI devices is now available from FDA in the United States and the Ministry of 
Economy, Trade and Industry of Japan; however, these documents do not establish legally 
enforceable responsibilities.7 
 
SUMMARY  
AI is expected to significantly enhance and supplement the endoscopists’ performance in 
polyp detection and characterization. Such improvement could contribute to higher ADR 
(ultimately reduction of colorectal cancers) and potential implementation of a resect and discard 
paradigm. Although AI powered CADe/CADx systems have shown a great premise in 
colonoscopy, the quality of reported AI systems varies significantly. Once the efficacy and 
reproducibility of AI systems are validated in rigorously designed trials, they may have a 
significant impact on colonoscopy practice. 
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FIGURE LEGENDS 
Figure 1. Two types of outputs for automated polyp detection. A, Presence of the polyp is 
indicated by a visible alarm outputting color outside the endoscopic monitor. B, Polyp location is 
indicated by putting a visible rectangle. 
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ABBREVIATIONS: 
 
ADR: adenoma detection rate. AI: artificial intelligence. APC: adenoma per 
colonoscopy. CADe: computer aided detection. CADx, computer aided characterization. 
CRC: colorectal cancer. DL: Deep Learning. FDA: Food and Drug Administration. LIF: 
laser-induced fluorescence. NBI: narrow band imaging. NPV: negative predictive value. 
PIVI: preservation and incorporation of valuable endoscopic innovations. PMR: polyp 
miss rate. PPV: positive predictive value. SSLs: sessile serrated lesions. 
 
